IONTOPHORESIS Versus Ultrasound ON UPPER TRAPEZIUS MYOFASCIAL TRIGGER POINTS

Sponsor

Cairo University (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05474898

Collaborator

(none)

Enrollment

Arms

2.1

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

to investigate the effects of Magnesium Sulphate Iontophoresis versus High Power Pain Threshold Ultrasound on pain, function and range of motion on active MTrPs found in the upper trapezius.

Condition or Disease	Intervention/Treatment	Phase
Trigger Point Pain, Myofascial	Other: Magnesium Sulphate Iontophoresis +conventional therapy Other: High- Power Pain Threshold Ultrasound +conventional therapy Other: conventional theapy	N/A

Detailed Description

Myofascial pain syndrome (MPS) is a musculoskeletal chronic pain disorder that affects the majority of pain population and characterized by the presence of trigger points. MPS is usually associated with tenderness, spasm, movement limitation and referred pain .

Myofascial trigger points (MTrPs) are hyperirritable taut fibers of skeletal muscle. The taut fibers within the muscle create palpable nodules that may cause local pain, and refer pain elsewhere with soft tissue examination .

Study Design

Study Type:

Interventional

Anticipated Enrollment :

90 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Participant)

Primary Purpose:

Treatment

Official Title:

Magnesium Sulphate Iontophoresis Versus High- Power Pain Threshold Ultrasound ON Upper Trapezius Myofascial Trigger Points

Anticipated Study Start Date :

Jul 30, 2022

Anticipated Primary Completion Date :

Sep 1, 2022

Anticipated Study Completion Date :

Oct 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Group (A)	Other: Magnesium Sulphate Iontophoresis +conventional therapy will receive Mgso4 Iontophoresis on the upper trapezius twice a week/4weeks
Experimental: Group (B)	Other: High- Power Pain Threshold Ultrasound +conventional therapy will receive HPPT-US on the upper trapezius twice a week/4weeks
Other: Group (c)	Other: conventional theapy will receive postural correction exercise-stretching and strengthening twice a week/4weeks

Arm

Intervention/Treatment

Experimental: Group (A)

Other: Magnesium Sulphate Iontophoresis +conventional therapy

will receive Mgso4 Iontophoresis on the upper trapezius twice a week/4weeks

Experimental: Group (B)

Other: High- Power Pain Threshold Ultrasound +conventional therapy

will receive HPPT-US on the upper trapezius twice a week/4weeks

Other: Group (c)

Other: conventional theapy

will receive postural correction exercise-stretching and strengthening twice a week/4weeks

Outcome Measures

Primary Outcome Measures

pain intensity [up to four weeks]
The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

Secondary Outcome Measures

Pain pressure threshold (PPT) [up to four weeks]
Pain pressure threshold (PPT) is used to measure deep muscular tissue sensitivity by Algometer.
neck disability [up to four weeks]
will be measured by Arabic neck disability index
range of motion [up to four weeks]
will be measured by myrin gravity reference goniometer

Eligibility Criteria

Criteria

Ages Eligible for Study:

19 Years to 23 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Subjects, with age ranged from 19-23 years (Forman et al, 2014) from both genders. The subjects had active MTrPs in the upper fibers of trapezius muscle.

Exclusion Criteria:

• History of whiplash injury.
History of cervical spine surgery.
Cervical radiculopathy or myelopathy.
Having undergone physical therapy within the past three months before the study.
Non- rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection.
Rheumatologic condition as poly-articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Hend Hamdy, lecturer of pt for basic science department, Cairo University

ClinicalTrials.gov Identifier:

NCT05474898

Other Study ID Numbers:

p.T.RCE/012/003552

First Posted:

Jul 26, 2022

Last Update Posted:

Jul 26, 2022

Last Verified:

Jul 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Myofascial Pain Syndromes

Magnesium Sulfate

Study Results

No Results Posted as of Jul 26, 2022